Skip to main content
. 2021 Dec 10;26(2):410–421. doi: 10.1111/jcmm.17093

FIGURE 1.

FIGURE 1

IGF2BP3 is increased in nasopharyngeal carcinoma based on GEO datasets. (A) The differential expression of IGF2BP3 mRNA levels between nasopharyngeal carcinoma and adjacent normal tissues in the GEO database (GSE12452, GSE13597, GSE53819, GSE61218, GDE64634, GSE126683). (B) Gene set enrichment analysis (GSEA) indicated that IGF2BP3 is positively involved in mTORC1 signalling. Wilcoxon rank‐sum tests were used to evaluate the differential expression levels of IGF2BP3 between NPC and normal tissues